BioRestorative adds lender designees Grasso, Field, Dhaliwal to board after three director resignations

• BioRestorative Therapies reshaped its board, adding lender designees Mika Grasso, Katharyn Field, Jatinder Dhaliwal on June 12, 2026.
• Changes followed the June 11, 2026 resignations of directors Francisco Silva, Nickolay Kukekov, Patrick F. Williams.
• Grasso, an investment director at a family office, previously worked at Zions Capital Markets, Paulson Investment, Goldman Sachs.
• Field, CEO of iSpecimen, previously led Halo Collective; Dhaliwal, a pharmacist, has served as CEO and director across Canadian and U.S.-listed companies.
• Lance Alstodt stays board chair; David Rosa remains a director, taking compensation committee chair duties.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001021771-26-000091), on June 12, 2026, and is solely responsible for the information contained therein.